BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 29092956)

  • 1. "Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.
    Kurnit KC; Bailey AM; Zeng J; Johnson AM; Shufean MA; Brusco L; Litzenburger BC; Sánchez NS; Khotskaya YB; Holla V; Simpson A; Mills GB; Mendelsohn J; Bernstam E; Shaw K; Meric-Bernstam F
    Cancer Res; 2017 Nov; 77(21):e123-e126. PubMed ID: 29092956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian approach to incorporating different types of biomedical knowledge bases into information retrieval systems for clinical decision support in precision medicine.
    Balaneshinkordan S; Kotov A
    J Biomed Inform; 2019 Oct; 98():103238. PubMed ID: 31301513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.
    Dumbrava EI; Meric-Bernstam F
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29212833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-Based Precision Oncology with the Cancer Targetome.
    Blucher AS; Choonoo G; Kulesz-Martin M; Wu G; McWeeney SK
    Trends Pharmacol Sci; 2017 Dec; 38(12):1085-1099. PubMed ID: 28964549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision Oncology: Between Vaguely Right and Precisely Wrong.
    Brock A; Huang S
    Cancer Res; 2017 Dec; 77(23):6473-6479. PubMed ID: 29162615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Tumor Boards: Realizing Precision Oncology Therapy.
    Patel M; Kato SM; Kurzrock R
    Clin Pharmacol Ther; 2018 Feb; 103(2):206-209. PubMed ID: 29134641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in precision therapy in pediatric oncology.
    O'Donohue T; Farouk Sait S; Glade Bender J
    Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision oncology based on omics data: The NCT Heidelberg experience.
    Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
    Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
    Lin VTG; Yang ES
    J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision oncology: East meets West.
    Subbiah V; Rodon J; Yap TA
    Int J Cancer; 2018 May; 142(9):1734-1737. PubMed ID: 29243227
    [No Abstract]   [Full Text] [Related]  

  • 19. Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With Cancer.
    Borad MJ; LoRusso PM
    Mayo Clin Proc; 2017 Oct; 92(10):1583-1591. PubMed ID: 28982488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
    Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
    Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.